HomeBiotech

Biotech

CyGenica Limited Secures USFDA Approval for Orphan Drug Designation for Novel Drug Conjugate in Glioblastoma Multiforme Treatment

CyGenica Limited Secures USFDA Approval for Orphan Drug Designation for Novel Drug Conjugate in Glioblastoma Multiforme Treatment

September 12, 2023

South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development

South Korean Biotech Company Portrai Inc. Adopts Infortrend Storage to Enable AI Data Analysis for Pharmaceutical Drug Development

September 12, 2023

AGS Therapeutics Named among Business Worldwide Magazines 20 Most Innovative Companies to Watch in 2023

AGS Therapeutics Named among Business Worldwide Magazines 20 Most Innovative Companies to Watch in 2023

September 12, 2023

IDEAYA Announces Phase 1 Expansion and Preliminary Clinical Proof-of-Concept for Potential First-in-Class PARG Inhibitor IDE161 in HRD Solid Tumors

IDEAYA Announces Phase 1 Expansion and Preliminary Clinical Proof-of-Concept for Potential First-in-Class PARG Inhibitor IDE161 in HRD Solid Tumors

September 11, 2023

Visgenx Presents Poster at the Cell and Gene Therapy: Advancing Next Generation Therapies, West Coast Symposium

Visgenx Presents Poster at the Cell and Gene Therapy: Advancing Next Generation Therapies, West Coast Symposium

September 11, 2023

Medivir’s Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study

Medivir’s Partner Tango Therapeutics received FDA clearance to start the TNG348 phase 1/2 clinical study

September 11, 2023

Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium

Shine Technologies and Curadh MTR Announce Expanded Strategic Partnership to Advance Cancer Therapies using Terbium and Lutetium

September 11, 2023

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

PeproMene Bio, Inc. Announced Completion of the First Dose Cohort and Opening of the Second Dose Cohort in Its B-cell Non-Hodgkin Lymphoma (B-NHL) Phase 1 Clinical Trial of PMB-CT01 (BAFFR-CAR T Cells)

September 11, 2023

Mirati Presents Two-Year Follow-Up Data from KRYSTAL-1 Study Demonstrating Durable Response and Long-Term Overall Survival at 2023 World Conference on Lung Cancer

Mirati Presents Two-Year Follow-Up Data from KRYSTAL-1 Study Demonstrating Durable Response and Long-Term Overall Survival at 2023 World Conference on Lung Cancer

September 10, 2023

EQUASHIELD: The Leading Provider of Closed System Transfer Devices Celebrates Five Years as the Most Used Device in Hazardous Drug Administration and Preparation

EQUASHIELD: The Leading Provider of Closed System Transfer Devices Celebrates Five Years as the Most Used Device in Hazardous Drug Administration and Preparation

September 9, 2023

« 1 … 86 87 88 89 90 … 126 »